Increased TAMs and CD68+ phenotype in the tumor bulk and infiltrative areas and increased TAMs after neoadjuvant chemotherapy (NAC) is associated with response to NAC in invasive breast cancer. The gene discussed is CD68; the disease is invasive breast carcinoma.